Cart
sales@molnova.com
6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one
CAS No. 122001-78-9
6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one ( 6,7-Dihydro-5H-cyclopenta[c]pyridazin-3-ol; 2H,3H,5H,6H,7H-cyclopenta[c]pyridazin-3-one; ZINC4342676 )
Catalog No. M28553 CAS No. 122001-78-9
6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one is an intermediate used to synthesize Pyridazine derivatives.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 68 | Get Quote |
|
| 25MG | 115 | Get Quote |
|
| 50MG | 173 | Get Quote |
|
| 100MG | 258 | Get Quote |
|
| 200MG | 388 | Get Quote |
|
| 500MG | 737 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one
-
NoteResearch use only, not for human use.
-
Brief Description6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one is an intermediate used to synthesize Pyridazine derivatives.
-
Description6,7-Dihydro-2H-cyclopenta[c]pyridazin-3(5H)-one is an intermediate used to synthesize Pyridazine derivatives.
-
Synonyms6,7-Dihydro-5H-cyclopenta[c]pyridazin-3-ol; 2H,3H,5H,6H,7H-cyclopenta[c]pyridazin-3-one; ZINC4342676
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number122001-78-9
-
Formula Weight136.2
-
Molecular FormulaC7H8N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=c1cc2CCCc2n[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Na Ri Kim, et al. Discovery of a new and efficient small molecule for neuronal differentiation from mesenchymal stem cell.
molnova catalog
related products
-
Angiotensin 1/2 (1-9...
Angiotensin 1/2 (1-9)TFA is containing the amino acids 1-9 that are converted from Angiotensin I/II peptide.
-
4-Amino-5-Bromopyrro...
4-Amino-5-Bromopyrrolo[2,3-D]Pyrimidine is a marine derived natural products found in Echinodictyum sp.
-
ANP (1-28), human, p...
Atrial natriuretic peptide (ANP), a stimulator of particulate guanylate cyclase, has been found to protect against reoxygenation-induced hypercontracture in isolated cardiomyocytes by increasing cyclic guanosine monophosphate synthesis; ANP also contributes to stimulation of lipolysis during repeated bouts of exercise and in the control of lipolysis during exercise.
